Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies
Open Access
- 13 August 2009
- journal article
- research article
- Published by EDP Sciences in Veterinary Research
- Vol. 40 (6), 63-15
- https://doi.org/10.1051/vetres/2009046
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) can induce reproductive disorders and is involved in the porcine respiratory disease complex, causing tremendous economic losses to the swine industry. Inactivated PRRSV vaccines are preferred over attenuated vaccines because of their safety and flexibility towards emerging virus strains, but the efficacy of current inactivated PRRSV vaccines is questionable. In this study, experimental inactivated PRRSV vaccines were developed, based on two formerly optimized inactivation procedures: UV irradiation and treatment with binary ethylenimine (BEI). In a first experiment, it was shown that vaccination with UV- or BEI-inactivated virus in combination with Incomplete Freund's Adjuvant induced virus-specific antibodies and strongly primed the virus-neutralizing (VN) antibody response. Subsequently, the influence of adjuvants on the immunogenicity of neutralizing epitopes on the inactivated virus was investigated. It was shown that vaccination with BEI-inactivated virus in combination with a commercial oil-in-water adjuvant induced high titers (3.4 log(2)) of VN antibodies in 6/6 pigs, instead of only priming the neutralizing antibody response. After challenge, neutralizing antibody titers in these vaccinated animals rose to a mean value of 5.5 log(2), and the duration of the viremia was reduced to an average of 1 week. This study shows that, by the use of an optimized inactivation procedure and a suitable adjuvant, inactivated PRRSV vaccines can be developed that induce VN antibodies and offer partial protection upon challenge.Keywords
This publication has 34 references indexed in Scilit:
- Assessing the functionality of viral entry-associated domains of porcine reproductive and respiratory syndrome virus during inactivation procedures, a potential tool to optimize inactivated vaccinesVeterinary Research, 2009
- Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigsVirology, 2006
- Nidovirales: Evolving the largest RNA virus genomeVirus Research, 2006
- Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virusJournal of General Virology, 2005
- Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophagesVeterinary Immunology and Immunopathology, 2004
- Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacyVaccine, 2004
- Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccinesVeterinary Microbiology, 2003
- Appearance of acute PRRS‐like symptoms in sow herds after vaccination with a modified live PRRS vaccineVeterinary Record, 1997
- Isolation of Swine Infertility and Respiratory Syndrome Virus (Isolate ATCC VR-2332) in North America and Experimental Reproduction of the Disease in Gnotobiotic PigsJournal of Veterinary Diagnostic Investigation, 1992
- Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimineVaccine, 1990